Skip to main content

Want a detailed portfolio tracker?

Third Harmonic Bio (THRD) P/E (2022 - 2026)

Third Harmonic Bio (THRD) P/E from Sep 14, 2022 to Jul 21, 2026. The TTM Third Harmonic Bio (THRD) P/E is -4.42. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Third Harmonic Bio (THRD)

YearP/EChange
2026-4.42N/A
2025-4.42-54.46%
2024-9.72-20.51%
2023-12.22+1772.36%
2022-0.65N/A

Comparison Third Harmonic Bio (THRD) P/E with competitors

Third Harmonic Bio (THRD) P/E is -4.42.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.10%
ENLVEnlivex Ltd0.07-101.69%
FGENFibroGen Inc0.24-105.43%
CHRSCoherus Biosciences Inc0.85-119.18%
FBIOFortress Biotech Inc0.95-121.45%
ORMPOramed Pharmaceuticals Inc1.50-133.97%
AGENAgenus Inc3.01-168.02%
INVAInnoviva Inc3.15-171.28%
VXRTVaxart Inc3.55-180.23%
CRMDCorMedix Inc3.63-182.01%
CVACCureVac N.V.4.45-200.48%
GLPGGalapagos NV4.86-209.82%
SRPTSarepta Therapeutics Inc4.88-210.34%
ABEOAbeona Therapeutics Inc5.39-221.76%
ABUSArbutus Biopharma Corp5.60-226.47%
ZVRAZevra Therapeutics Inc5.89-233.06%
SPROSpero Therapeutics Inc6.23-240.77%
CGENCompugen Ltd6.31-242.70%
RIGLRigel Pharmaceuticals6.87-255.31%
SLXNSilexion Therapeutics Corp7.30-264.90%
OMEROmeros Corporation9.26-309.26%
AUPHAurinia Pharmaceuticals Inc9.58-316.63%
PLXProtalix BioTherapeutics Inc10.89-346.15%
ACADAcadia Pharmaceuticals Inc11.73-365.08%
TBPHTheravance Biopharma Inc12.26-377.14%
ADMAAdma Biologics Inc12.42-380.66%
HRMYHarmony Biosciences Holdings Inc13.82-412.35%
SABSSAB Biotherapeutics Inc14.14-419.49%
NAGENiagen Bioscience Inc14.82-434.90%
INCYIncyte Corp15.82-457.61%
REGNRegeneron Pharmaceuticals Inc15.86-458.38%
PBYIPuma Biotechnology Inc17.32-491.35%
CPRXCatalyst Pharmaceuticals Inc17.44-494.15%
EXELExelixis Inc17.54-496.38%
TGTXTG Therapeutics Inc18.97-528.65%
MDXGMimedx Group Inc20.55-564.51%
XOMAXOMA Royalty Corp22.87-617.00%
ARGXArgen X SE24.30-649.17%
CTMXCytomX Therapeutics Inc24.82-661.00%
XOMAOXOMA Royalty Corp25.34-672.83%
HALOHalozyme Therapeutics Inc25.62-679.14%
XOMAPXOMA Royalty Corp25.67-680.19%
VRTXVertex Pharmaceuticals Inc27.99-732.73%
RPRXRoyalty Pharma plc - Class A28.69-748.38%
SLNOSoleno Therapeutics Inc29.02-755.79%
ASNDAscendis Pharma A/S30.09-779.98%
LGNDLigand Pharmaceuticals Inc - Class B37.91-956.87%
APLSApellis Pharmaceuticals Inc39.02-981.94%
BMRNBiomarin Pharmaceutical Inc42.21-1054.06%
KRYSKrystal Biotech Inc45.34-1124.84%
ONCBeiGene Ltd69.54-1671.73%
PHARPharming Group N.V.75.03-1795.70%
TECHBio-Techne Corp101.96-2404.42%
VCELVericel Corp109.92-2584.40%
ALNYAlnylam Pharmaceuticals Inc117.96-2766.20%
GMABGenmab140.29-3270.80%
TLXTelix Pharmaceuticals Ltd162.15-3764.92%
CORTCorcept Therapeutics Inc212.86-4910.92%